4Guan Y,Br~-,yer M D.Targeting peroxis~mle proliferalor-aclivated rec~ptors(PPARs)in kidney and urologic' disease.Minerva Urol Nefi'ol,2002.54(2):65-79.
5Moo/ha V K.Lirdgrenl C M.E,'ikscon K F.el al.PGC-lalpha- responsive genes involved ill oxidalive phosphorlation are coordinately downregulated in human diabetes.Nat Gene|.2003. 34(3):267-273.
6Yoon J C,Puigserver P,Chen G,et aI.Control ot" hepalic glueoneogenesis through the transcripliomll eoaeliwltor PGC-I. Nalure,2001,413(6852): 131 - 138.
7Koo S H.Satoh H.Herzig S.e/aI.PGC-I pro, moles insulin resislant.e in liver through PPAR-alpha-dependenl indt,c/ion of TRB-3.NaI Med,2004,10(5):530-534.
8Hmlmnm~tedl A,Jansson P A.Wesslau C.e! al.Reduced exln~ssion of PGC-1 and Insulin-signaling molecules in adipose tissue is associated with insulin resislance.Bioehem Biophys Res Co,nmun, 2003,301 (2):578-582.
9Tordjmml K,Bemal-Mizrachi C,Zemmly L,et "aI.PPAR ot deficiency reduces insulin resistance and athemselerosis In at~~E-mJll mice. J Clin I nvest,2001,107(8): 1025-1034.
10Grundy SM,Cleeman JI,Daniels SR,et al.Diagnosis and management of the metabolic syndrome:an Ameriean Heart Association/National Heart,Lung,and Blood Institute scientific statement:Executive Summary[J].Crit Pathw Cardiol,2005,4(4):198-203.
